News
It always comes back to knowing your definition of success–and for complex workflows, you also need to think about what ...
The rising prevalence of cancer worldwide, increasing adoption of minimally invasive diagnostic tests, and advances in ...
14h
GlobalData on MSNJessa Ziekenhuis to adopt SOPHiA GENETICS platform for cancer care
The integrated platform decreases manual effort by 30–50%, reduces total expenses by up to 25%, and speeds up turnaround ...
This infographic will explore how NGS has contributed to advances in personalized cancer treatment, microbiome research and ...
SOPHiA Genetics & Jessa Ziekenhuis partner to bring cutting edge genomic testing and oncology research to cancer patients across Belgium: Boston Monday, September 8, 2025, 16:00 H ...
PredicineCARE, a urine-based test, is under FDA review as a companion diagnostic for bladder cancer, building on previous ...
Use AutoNorm™ to manage the PCR at the level of individual wells. By guaranteeing individual reactions are amplified to the ...
14d
AZoLifeSciences on MSNExploring the Regulatory Potential of "Junk DNA"
The non-coding genome, once referred to as "junk DNA," is now understood to be a fundamental regulator of gene expression and ...
5 latest biotechnology breakthroughs, from genome sequencing to microbiome manipulation, revolutionizing medicine, ...
Illumina has begun rolling out its protein research platform, powered in part by tech from SomaLogic, which the DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results